The
World Health Organisation (WHO) estimates that about 25 percent of
medicines consumed in some developing countries, including Nigeria, are
counterfeit or substandard.
Painting
the stark scenario at a seminar in Lagos, Lekan Asuni, President of
the Association of Nigerian Representatives of Overseas Pharmaceutical
Manufacturers (NIROPHARM), described the situation as a global
challenge requiring swift counter-measures.
He
said that drug counterfeiting exposes consumers to dangerous and
ineffective products and retailers to reduced consumer demand and
profits.
"It
deprives governments of revenues for vital services, it forces higher
burdens on taxpayers and dislocates hundreds of thousands of jobs."
Asuni said that the WHO estimates global sales of counterfeit medicines at over $40 billion a year.
"And we all know that Nigeria is not left out of this crisis," he added.
He
blamed inadequate legislation, weak enforcement and a poor
distribution system for encouraging drug-counterfeiting in the country.
No comments:
Post a Comment